Tatiana Shcheglova

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection”.

An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection

Journal of Clinical Investigation(2020)10.1172/jci142823

N/A

0DataRank · unranked

35 citations

Mariam M. George, Marmar M. Moussa, Adam T. Hagymasi, Sahar Al Seesi, Tatiana Shcheglova +8 more

CRISPR-guided reversion reveals the immunogenicity of a “non-MHC binding” cancer neoepitope in vivo

Research Square(2020)10.21203/rs.3.rs-119173/v1

N/A

0DataRank · unranked

0 citations

Marmar R. Moussa, Ryan Englander, Summit Singhaviranon, Justine Michaux, HuiSong Pak +11 more

Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope

Nature Communications(2021)10.1038/s41467-021-26646-5

N/A

0DataRank · unranked

30 citations

Marmar R. Moussa, Ryan Englander, Summit Singhaviranon, Justine Michaux, HuiSong Pak +11 more

A frameshift-generated cancer neoepitope that controls tumor burden in prophylaxis as well as therapy

The Journal of Immunology(2025)10.1093/jimmun/vkaf016

N/A

0DataRank · unranked

0 citations

Cory A Brennick, Adam T. Hagymasi, Tatiana Shcheglova, Sahar Al Seesi, Tatiana J. Rosales +4 more